
BACKGROUND: Patients who leave the Emergency Department (ED) before receiving care, known as Did Not Wait (DNW), pose potential safety risks that may reflect system pressures. Understanding differences between DNW patients and those who remain for care can inform strategies to reduce adverse outcomes. METHODS: A quantitative comparative observational study, guided by the STROBE checklist, was conducted in a quaternary ED in Victoria, Australia, comparing DNW patients with those who received treatment. RESULTS: Of 37,137 presentations, 1064 (2.9%) were DNW, while 36,073 (97.1%) were treated. DNW patients were younger than treated patients (median age 37 vs. 46 years; p < 0.001), and more likely to be triaged to lower acuity categories (p < 0.001). Nevertheless, 36.4% of DNW patients were triaged as Australian Triage Scale Category 3. Compared with busy conditions severe overcrowding was associated with more than double the odds of DNW (AOR = 2.53; 95% CI: 1.99-3.24; p < 0.001), while dangerously overcrowded conditions increased the odds more than 15-fold (AOR = 14.99; 95% CI: 10.15-22.05; p < 0.001). CONCLUSION: Study findings suggest that extreme crowding, rather than patient characteristics, is the principal determinant of DNW. These shifts focus from descriptive patient profiling towards interpreting DNW as an indicator of system performance.
ABSTRACT Objective To evaluate documented adherence to Australian guideline recommendations for emergency department (ED) management of patients receiving human immunodeficiency virus post‐exposure prophylaxis (HIV PEP) and explore variation by exposure category. Methods A retrospective, dual‐site cohort study included consecutive patients dispensed HIV PEP at two Australian EDs between 1 June 2020 and 1 June 2025. Patients with known HIV infection or managed through a dedicated sexual assault pathway were excluded. Records were reviewed for documented exposure‐risk assessment, applicable baseline investigations, antiretroviral regimen, counselling, discharge information and clinician‐documented follow‐up plan or referral. Exploratory comparisons were undertaken by exposure category. Results Seventy‐seven patients were included. Clinician documented follow‐up plan or referral was documented in 73 (94.8%), and 61 (79.2%) received the first‐line regimen recommended by the applicable guidance. Complete recommended management was documented in 8 (10.4%), exposure‐risk assessment in 36 (46.8%) and complete baseline investigations in 10 (13.0%). Compared with occupational and other community exposures, consensual sexual exposures had lower documented exposure‐risk assessment (36.2% vs. 78.9%; OR: 0.16, 95% CI: 0.03–0.57) and complete baseline investigations (5.2% vs. 36.8%; OR: 0.10, 95% CI: 0.01–0.50). Conclusions Among patients dispensed HIV PEP, recommended regimens and follow‐up were commonly documented, but complete recommended assessment and investigation were uncommon. A structured ED body‐fluid exposure pathway should be prospectively evaluated.
ABSTRACT Patients in rural and remote Australia often present later and with more advanced disease compared to major and regional cities. Drawing on experience as a junior doctor in the Cape and in rural emergency departments, this article explores how geographic isolation, limited resources, health literacy challenges and inequities in access shape these presentations. Cases include a critically unwell patient managed overnight in a makeshift intensive care bay when weather delayed retrieval, a family of young children with Norwegian Scabies, and a partial finger amputation complicated by weekend staffing shortages. The article reviews Australian evidence on sepsis, scabies and its link to rheumatic heart disease and trauma outcomes, all of which tend to be more challenging to manage. Timely care in rural and remote communities depends on early recognition, clear communication and close collaboration between rural generalists, FACEMs, retrieval services and specialist teams.
ABSTRACT Objective Clinical debriefing should be standard practice in healthcare, but in most emergency departments implementation lags behind evidence. This post‐implementation evaluation examined the performance of a clinical debriefing programme in a tertiary care paediatric emergency department, exploring implementation, key enablers and barriers to use. Methods This qualitative descriptive, post‐implementation study used semi‐structured interviews, with deductive analysis guided by a context–mechanism–outcome framework. Results Twenty‐one multidisciplinary staff were interviewed. Debriefing became embedded in routine practice through organisational endorsement, structured facilitation and inclusive participation. Participants reported improved clinical reasoning, emotional regulation, psychological safety and interprofessional relationships. Debriefing strengthened support for junior staff, enhanced relational co‐ordination across disciplines, facilitated more timely quality and safety actions and built nursing capacity to lead debriefs. Time was the principal barrier, but reframing debriefing as an integral component of clinical care enabled its routine delivery. Conclusions Clinical debriefing was embedded in routine practice through interactions between organisational context and implementation mechanisms, with successful implementation relying on both the intervention and the conditions enabling it. Benefits for clinical practice, staff well‐being, teamwork, enhanced support for the junior workforce and timely quality improvement initiatives were described. This study advances current understanding and provides direction for teams seeking to implement or optimise debriefing within their own departments.
ABSTRACT Objectives Pain management is integral to prehospital trauma care. However, due to multiple challenges, pain is frequently undertreated despite important physiologic and psychologic implications. Among these challenges is uncertainty regarding the safety and effectiveness of pharmacologic agents administered enroute. We aimed to evaluate the level of evidence for the safety and effectiveness of prehospital pharmacologic analgesia for acutely injured adult trauma patients. Methods An electronic database search of PUBMED, Google Scholar, Cochrane Library, Embase and Scopus for studies that reported on safety and/or effectiveness of prehospital pharmacologic analgesia for acutely injured adults (aged > 15 years) from January 1st, 2014, to January 1st, 2026. Non‐original studies, paediatric studies, studies of non‐pharmacologic agents or non‐systemic administration (e.g., topical) were excluded. Results Seventeen studies, involving 17,115 patients, met the inclusion criteria. The studies consisted of 6 randomized controlled trials, 5 retrospective cohort studies, one retrospective comparative study, one retrospective observational study, two prospective observational studies, one prospective cohort study and one non‐randomized clinical trial. Agents included opioids, ketamine, methoxyflurane and paracetamol. Apart from one study of opioid therapy, no drug‐attributed serious adverse events were reported. Minor adverse effects such as nausea, dizziness, dysphoria, agitation and drowsiness were common. All agents demonstrated effectiveness to varying levels. Conclusions Current evidence demonstrates an overall favourable safety and effectiveness profile of prehospital analgesia for adult trauma patients. However, considering the wide prehospital prevalence of injury‐related pain, evidence is limited by scope, methodology and variations of treatment protocols.